Please login to the form below

Not currently logged in
Email:
Password:

CEVEC and Catalent partner on cell lines

CEVEC Pharmaceuticals and Catalent Pharma Solutions have launched a joint commercial cell line development service for pharma and biotech customers worldwide

CEVEC Pharmaceuticals and Catalent Pharma Solutions have launched a joint commercial cell line development service for pharma and biotech customers worldwide. 

The offering combines the benefits of CEVEC's human cell line, CAP-Technology, with Catalent's unique GPEx (Gene Product Expression) Technology to generate high expressing stable human cell lines in a much shorter timeframe than traditional methods.


Wolfgang Kintzel, managing director of CEVEC, said: "The combined offering is a very compelling value proposition for clients looking to outsource cell line development and potential downstream cGMP upscaling while looking for the highest quality using a human cell line."

16th June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics